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Abstract
Background: The European Centres of Reference Network for Cystic Fibrosis (ECORN-CF) established an Internet
forum which provides the opportunity for CF patients and other interested people to ask experts questions about
CF in their mother language. The objectives of this study were to: 1) develop a detailed quality assessment tool to
analyze quality of expert answers, 2) evaluate the intra- and inter-rater agreement of this tool, and 3) explore
changes in the quality of expert answers over the time frame of the project.
Methods: The quality assessment tool was developed by an expert panel. Five experts within the ECORN-CF
project used the quality assessment tool to analyze the quality of 108 expert answers published on ECORN-CF
from six language zones. 25 expert answers were scored at two time points, one year apart. Quality of answers was
also assessed at an early and later period of the project. Individual rater scores and group mean scores were
analyzed for each expert answer.
Results: A scoring system and training manual were developed analyzing two quality categories of answers: content
and formal quality. For content quality, the grades based on group mean scores for all raters showed substantial
agreement between two time points, however this was not the case for the grades based on individual rater scores.
For formal quality the grades based on group mean scores showed only slight agreement between two time points
and there was also poor agreement between time points for the individual grades. The inter-rater agreement for
content quality was fair (mean kappa value 0.232 ± 0.036, p < 0.001) while only slight agreement was observed for
the grades of the formal quality (mean kappa value 0.105 ± 0.024, p < 0.001). The quality of expert answers was rated
high (four language zones) or satisfactory (two language zones) and did not change over time.
Conclusions: The quality assessment tool described in this study was feasible and reliable when content quality
was assessed by a group of raters. Within ECORN-CF, the tool will help ensure that CF patients all over Europe
have equal possibility of access to high quality expert advice on their illness.
Background
Cystic fibrosis (CF) is an autosomal recessive inherited
disease caused by mutation of the cystic fibrosis trans-
membrane conductance regulator (CFTR) gene, coding
for a protein functioning as a transmembrane epithelial
chloride channel [1]. It is a multi-system disease charac-
terized by progressive pulmonary damage leading to
respiratory failure, pancreatic dysfunction, liver disease,
gut motility problems and elevated sweat electrolytes.
CF occurs world-wide and is the most common autoso-
mal recessive lethal hereditary disorder in Caucasians
with an incidence of approximately one in 2500 live
births [2,3].
A large multinational study on health which included
29025 CF patients across 35 European countries sug-
gests that the quality of care for CF patients is not equal
across Europe [4]. In some of the Eastern European
countries drugs, equipment and specialized care are not
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always easily available. In new EU member states,
specialized CF centres tend to be located in the most
populated areas with access to specialized care for
patients living in remote areas difficult or absent. Data
available from 2003 on the median gross domestic pro-
duct per person, a surrogate for health care spending,
was nine times higher in EU countries than in non-EU
countries [5]. The demographic data from the multina-
tional European study reveals that CF patients from EU
countries had a better survival than CF patients from
non-EU countries in 2003 [4]. To overcome some of
these differences between European countries, the
“European Centres of Reference Network for Cystic
Fibrosis” (ECORN-CF) project was initiated. The aim of
ECORN-CF was to facilitate access to specialized health
care counseling for all European CF patients and allow
easy access to expert advice in all member state lan-
guages. The project uses the Internet as a medium for
communication. This approach appears reasonable, as
Internet access for patients rose significantly in the last
10 years [6,7] and the Internet has become an important
medium for patients to get advice on their illness [8,9].
An Internet platform was established in the participat-
ing language zones (Czech, Dutch, English, German,
Greek, Lithuanian, Polish, Romanian and Swedish; later,
in October 2010, the French language zone joined the
expert advice system). This Internet platform enables CF
patients/lay people as well as clinicians to get expert
advice/answers to questions they pose in their mother
language.
The ECORN-CF patient advice platform is designed to
include a two-stage central quality control mechanism.
Firstly, expert answers are assessed on a national/lan-
guage-zone level (national platform) and secondly on a
European level (central English archive). At the national
level, the quality of the expert answer is assessed by a
national moderator. All expert answers are then translated
into English and a European moderator/coordinator
assesses the accuracy. The accuracy of the expert answers
is checked (i.e. their conformance to existing guidelines)
and judged as “good”, “with flaws” or “unacceptable”. In
case an answer was not scored as “good”, feedback is given
to the expert, and a proposal for an amended/extended
answer is provided according to published clinical guide-
lines. The aim of providing feedback is to improve the
quality of answers over time by a training effect and pro-
vide high quality expert answers. The final approved
expert answer is published on both the national platform
in the mother language of the questioner, and also in Eng-
lish in the central archive. If the questioners provide an
e-mail address, they are informed of the published answer.
If no guidelines on a particular area exist, then answers
are based on expert opinion. Such questions are marked
in the archive to indicate the need for a consensus and
development of guidelines.
A comprehensive literature review highlighted that
there are currently a number of Internet based patient
information/advice platforms in a range of chronic dis-
eases [8-11], however to our knowledge there are no
published studies assessing quality of expert advice. The
specific objectives of this study were to: 1) develop a
detailed quality assessment tool that could quantify the
quality of expert answers provided within the ECORN-
CF project, 2) evaluate the intra- and inter-rater agree-
ment of the quality assessment tool, and 3) explore
changes in quality of expert answers over the time
frame of the ECORN-CF project.
Methods
1. Development of a quality assessment tool to analyze
quality of expert answers
Two main categories of study quality were included in
the quality assessment tool; content quality and formal
quality. The category content quality included three sub-
scores to assess the correctness of the content, complete-
ness and openness of the answer. The category formal
quality included three sub-scores to assess comprehensi-
bility, extent of the answer and the way the questioner
was addressed. The above items were delineated and
weighted according to the importance of the item within
the category. A scale was defined to determine three
grades ("good”, “satisfactory” and “poor”) according to
the total score given. This first draft of the scoring system
was presented at the first quality round table of the
ECORN-CF project team on August 22nd, 2007. At this
meeting experts reviewed the proposed scoring system
and pilot tested it on a number of sample question/
answers. They provided feedback on key aspects of con-
tent and formal quality and the proposed scoring system.
Experts at the round table reported that the quality
assessment tool had good face and content validity and
was easy to use. Consensus was also reached on the con-
tent of a training manual. This training manual included
guidelines on each specific aspect of quality assessment
and also provided worked examples for users (see Addi-
tional File 1).
Out of all nine language zones participating in ECORN-
CF only six zones could be included in this study (Czech,
Dutch, English, German, Lithuanian, and Romanian). The
remaining three language zones (Greek, Polish and Swed-
ish) were excluded due to a small number of questions or
a late start date of the national website.
A total of 108 expert answers to questions posed by
patients or lay people from the start of the online period
of the respective language zone until the 3rd of July,
2009 (details see Table 1) were included in the analysis.
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Answers to questions posed by health care professionals
were excluded. The answers sent to the central English
archive by the national moderators prior to any modifi-
cations by the European coordinator were anonymized
and any information that would identify the country of
origin was removed to ensure that expert raters were
blinded. The order of expert answers from different
countries were randomly sorted and sent to the experts
to score in August 2009.
25 out of the 108 expert answers were scored twice by
each of the raters with a one year time interval. The
first scoring process took place in August 2008 for the
quality round table in Frankfurt in November, 2008. In
August 2009 expert answers were selected as described
above (including the 25 expert answers previously
scored) and sent to the experts to score. The experts
were directed not to look up their old records and it
was assumed that they did not remember their former
scores.
2. Assessment of intra- and inter-rater agreement
Five experts with different professional backgrounds
used the newly developed scoring system and training
manual to score each answer. VV (Czech Republic), KD
(Belgium) and HH (Germany) represented pediatric pul-
monologists specialized in CF care for children and
adults and JB (UK) represented respiratory physiothera-
pists specialized in CF care. BD (Germany) represented
the German CF-patient organization and not being a
care team member scored only the formal aspects of the
quality of answers.
2.1 Intra-rater agreement
For each rater, the percentage of expert answers scored
with the same grade on the two occasions and one or
two grades lower or higher were calculated. Further-
more, an average score for each answer was calculated
and graded as “good”, “satisfactory”, or “poor” and
agreement over time of this “all raters grade” evaluated.
2.2 Inter-rater agreement
To assess the inter-rater agreement within the group of
four (for the content quality score) respectively five (for
the formal quality score) raters, the percentage of expert
answers all raters gave the same grade to, and the per-
centage of expert answers with one or two grades
between the maximum and minimum grade given were
calculated. To describe the bias of raters to systemati-
cally score lower or higher than the mean score, the
percentage of expert answers which achieved more than
one point, and more than two points above or below
the mean score was calculated for each rater.
3. Evolution of quality of answers over time in the
participating language zones
Two time periods were defined for analyzing potential
trends of the quality of answers over time. The “early
period” comprised the first ten expert answers from the
beginning of the online period of the respective lan-
guage zone. The “later period” comprised the last ten
expert answers prior to the cut-off date (3rd July 2009).
The cut-off date was approximately two years after the
ECORN-CF project was initiated in May, 2007 (see
Table 1 for details of online dates, number of expert
Table 1 Selection of expert answers from participating language zones and respective time intervals
Language
zone
Online
since
No of answers early
period (time interval)
No of answers later
period (time interval)
Time span from begin of
early to end of later period
Time span from end of early
to begin of later period
Czech October 1,
2007
10 10 18.5 months 10.5 months
(7.11.07-29.1.08) (12.12.08-25.5.09)
Dutch March 5,
2008
10 10 15 months 6 months
(17.3.08-11.10.08) (12.4.09-14.6.09)
English October 1,
2007
10 10 19.5 months 4.3 months
(20.11.07-23.10.08) (2.3.09-3.7.09)
German October 1,
2007
10 10 20 months 18 months
(1.11.07-7.12.07) (2.6.09-28.6.09)
Lithuanian* January 31,
2008
5 8 16.3 months 7.3 months
(17.1.08-2.4.08) (12.11.08-28.5.09)
Romanian* December
19, 2007
5 10 17.8 months 5 months
(1.12.07-21.6.08) (16.11.08-21.5.09)
*Less than 10 question/answer pairs were available in some time periods.
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answers and time intervals). A reduced number of
expert answers were included from two language zones
due to a lower number of questions posted. The time
span between the “early” and “later” periods varied from
a minimum of approximately four months to a maxi-
mum of 18 months due to different dates of going
online and different numbers of asked questions.
Statistical Analysis
Descriptive statistics (percentages) were used to sum-
marize data. In order to describe intra- and inter-rater
agreement, Cohen’s weighted kappa values using linear
weights and the respective standard errors were calcu-
lated according to Fleiss et al. [12] The kappa values
were interpreted according to Landis and Koch (agree-
ment: poor < 0.00; slight 0.00-0.20; fair 0.21-0.40; mod-
erate 0.41-0.60; substantial 0.61-0.80; almost perfect
0.81-1.00) [13]. A p value of p < 0.05 was regarded to
be significant.
To assess the bias of raters, the mean difference
between the individual score given by a rater and the
mean score of the group of raters was calculated. Two-
sided t-test for paired data was used to determine statis-
tically significant differences between individual scores
and the mean score.
Two-sided t-tests were employed to compare mean
scores for answers given during the early period to
those given during the later period for all answers com-
bined and for each language zone separately.
Ethics committee
No formal ethical approval was obtained as the study
was not a matter of research on humans. All analyses
were restricted to existing data from a data base.
Results
1. Development of a quality assessment tool to analyze
quality of expert answers
The quality assessment tool, scoring system and training
manual are detailed in Table 2, and Additional File 1.
The aspect “correctness of the content” was regarded to
be of special importance. Therefore, this aspect was
labeled with zero points for a “poor” answer, three for a
“satisfactory” and six for a “good” answer, whereas in
contrast, the other two aspects of content quality (com-
pleteness and openness) were scored with zero, one and
two points for a “poor”, “satisfactory” or “good” answer,
respectively. If the content of the answer was not cor-
rect and achieved only zero points, the overall content
quality of the respective answer was graded as “poor”.
2. Assessment of intra- and inter-rater agreement
2.1 Intra-rater agreement
Concerning the content quality of answers, the intra-
rater agreement differed widely between the individual
raters. Results are shown in Table 3. The percentage of
expert answers which were graded twice in complete
congruence varied from 48-76% among raters, while the
percentage of expert answers which showed a discre-
pancy of one grade ranged from 16-48% and two grades
ranged from 0-5% among raters when scored twice.
Rater 1 showed a only a slight, rater 4 a fair and raters
2 and 3 a moderate intra-individual agreement over
time, estimated by weighted kappa values. Only for
raters 2 and 3, a significant agreement over time was
shown. When mean scores of all raters were analyzed
84% of expert answers had the same grade and the
remaining had a difference of one grade when scored
twice. In contrast to the individual scores, the grades
based on group mean scores between two time points
showed substantial agreement estimated by weighted
kappa values (p < 0.001).
For scoring of the formal quality of answers, there was
even less agreement between time points. The percentage
of expert answers scored twice by an individual in com-
plete congruence ranged from 40-80%, those scored with
one grade difference ranged from 16-48% and those
scored with two grades difference ranged from 4-14%
among raters (Table 3). The kappa values revealed a
slight agreement for raters 1,3 and 4, a moderate agree-
ment for rater 5 and a substantial agreement for rater 2.
Only for rater 2, a kappa value significantly different
from zero was observed. When mean scores of all raters
were analyzed, 52% of answers had the same grade and
44% and 4% had a difference of one and two grades
respectively, when scored twice. The grades based on
mean scores for formal quality showed only slight, non
significant agreement between two time points.
2.2 Inter-rater agreement
Raters agreed on the same grade in 42% of the expert
answers for content quality and in 26% for formal quality.
There was a discrepancy of one grade between the high-
est and lowest grade given from one or more raters (e.g.
“good” was the highest grade and “satisfactory” was the
lowest grade given for the respective answer) in 50% of
expert answers for content quality and in 38% of expert
answers for formal quality. For content quality, 8% of
expert answers got the highest grade “good” and the low-
est grade “poor” form different raters. For formal quality,
this was the case in 36% of expert answers. The inter-
rater agreement was calculated from 106 out of the 108
expert answers with a complete set of scores from all
raters available. For the content quality, the inter-rater
agreement was fair (mean kappa value 0.232 ± 0.036, p <
0.001) while only slight agreement was observed for the
grades of the formal quality (mean kappa value 0.105 ±
0.024, p < 0.001).
As individual raters judged a certain answer differ-
ently, we assessed the bias of individual raters to
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systematically score higher or lower than the mean
score of the group. The results are shown in Table 4. In
summary, the tendency of a single rater to score lower
or higher than the mean score was consistent for con-
tent and formal quality. Two raters had a clear tendency
to score below (differences between individual scores
and the mean score were significant, except for the con-
tent score of one rater) and two raters a clear tendency
to score above the mean with a significant difference to
the mean score of the group. One rater was relatively in
line with the mean of the group.
3. Evolution of quality of answers over time in the
participating language zones
Figures 1 and 2 show as an example the content and for-
mal quality for the Dutch language zone (for questions
from Belgium and the Netherlands). The mean score for
content quality decreased slightly from the early to the
later period (from 9.6 to 9.1 points), however the overall
content quality of expert answers from both periods
clearly were on a “good” level and did not differ statisti-
cally significant over time (p = 0.095, Figure 1). Concern-
ing the formal quality, all expert answers from the early
period were scored as “good”, and only two of ten from
the later period were scored as “satisfactory” (Figure 2).
The mean score for formal quality also decreased slightly
from the early to the later period (5.7 vs. 5.4 points,
respectively), however the grades based on those mean
scores from the two periods clearly were on a “good”
level and did not differ over time (p = 0.265).
A summary of the content/formal quality of answers
from all participating language zones at the early and
later period is shown in Figures 3 and 4. The Dutch and
English language zones were leading in respect of the
content quality of answers (Figure 3), with “good” quality
level during both periods. The Czech and German lan-
guage zone showed-on average-a bearly “good” content
quality and the Romanian and Lithuanian language zone
a “satisfactory” content quality in both periods. The for-
mal quality of answers (Figure 4) follows a similar pattern
with a clear “good” quality for the Dutch and English
answers, a “good” and bearly “good” quality for the Ger-
man and Czech answers, and a “satisfactory” quality for
the Lithuanian and Romanian answers. Taking all lan-
guage zones together, the content quality of answers
remained on a “good” quality level (Figure 3) and the
Table 2 Scoring system judging content and formal quality of expert answers
I. Content quality Grade Score (points)
I.1 Content correct, according to guidelines Poor 0
Satisfactory 3
Good 6
I.2 Completeness of the answer, suitability Poor 0
Satisfactory 1
Good 2
I.3 Openness (are rigid statements avoided without room for differing strategies) Poor 0
Satisfactory 1
Good 2
Total Score for content quality Poor 0-3
Satisfactory 4-7
Good 8-10
II. Formal quality Grade Score (points)
II.1 Comprehensive Style Poor 0
Satisfactory 1
Good 2
II.2 Personal Style Poor 0
Satisfactory 1
Good 2
II.3 Extent of answer Poor 0
Satisfactory 1
Good 2
Total Score for formal quality Poor 0-2
Satisfactory 3-4
Good 5-6
If I.1 “correctness of the content” was scored zero the answer was graded as poor overall.
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formal quality on a bearly “good” level (Figure 4) during
the early and later period. There were no significant dif-
ferences from the early to the later period in any of the
language zones or in the group of language zones taken
together.
Discussion
This study describes the development and use of a qual-
ity assessment tool for expert answers provided on an
Internet platform as part of the ECORN-CF project.
This tool assesses the content and formal quality of
answers, with a training manual available to guide raters.
The intra-rater agreement for both, content and formal
quality when scoring the same answer twice, one year
apart, showed poor agreement however, when group
mean scores of an expert panel were used there was
substantial agreement over time for content quality but
not for formal quality. Within the group of raters, the
inter-rater agreement for scoring the content quality
was fair, whilst it was only slight concerning the score
for formal quality. Furthermore, some raters showed a
substantial bias towards high or low scores. Therefore, it
becomes clear that in order to overcome the intra- and
inter-rater variability a group of raters is needed. How-
ever, the intra- and inter-rater agreement of scores for
formal quality of an answer could not be improved by
using the group mean score. Therefore, the quality
assessment tool presented in this study seems most ade-
quate for the judgment of content quality of expert
answers.
There were some expert answers that scored “good”
content quality at one time and then “poor” content qual-
ity at another time by the same person (two out of 25
expert answers) and there were also some that scored
“good” content quality by some raters and “poor” by
others (nine out of 108 expert answers). So in total eleven
answers were scored highly discrepantly. A number of
factors may have contributed to this. One explanation
Table 3 Intra-rater agreement between two assessments over time of individual raters and of all raters pooled
Content quality
Complete congruence Discrepancy 1 grade Discrepancy 2 grades weighted kappa ± standard error
Rater 1 11/23 11/23 1/23 0.020 ± 0.172
(48%) (48%) (4%) p = 0.909
Rater 2 19/25 6/25 0/25 0.559 ± 0.130
(76%) (24%) (0%) p < 0.001
Rater 3 17/25 8/25 0/25 0.460 ± 0.123
(68%) (32%) (0%) p < 0.001
Rater 4 13/22 8/22 1/22 0.236 ± 0.152
(59%) (36%) (5%) p = 0.120
Mean all raters 21/25 4/25 0/25 0.669 ± 0.149
(84%) (16%) (0%) p < 0.001
Formal quality
Complete congruence Discrepancy 1 grade Discrepancy 2 grades weighted kappa ± standard error
Rater 1 10/25 12/25 3/25 0.145 ± 0.150
(40%) (48%) (12%) p = 0.336
Rater 2 20/25 4/25 1/25 0.650 ± 0.133
(80%) (16%) (4%) p < 0.001
Rater 3 13/25 11/25 1/25 0.147 ± 0.161
(52%) (44%) (4%) p = 0.360
Rater 4 11/22 8/22 3/22 0.000 ± 0.000
(50%) (36%) (14%) p = 1
Rater 5 19/24 4/24 1/24 0.410 ± 0.249
(79%) (17%) (4%) p = 0.100
Mean all raters 13/25 11/25 1/25 0.169 ± 0.150
(52%) (44%) (4%) p = 0.260
25 expert answers were scored at two different points in time by the same raters. The numbers represent the number of expert answers (percentage in brackets)
that were scored with the same grade twice (complete congruence), that were scored the second time one grade lower or higher than the first time
(discrepancy 1 grade) and that were scored two grades lower or higher the second time (discrepancy 2 grades). If the total number of expert answers is lower
than 25, the respective rater regarded some of the expert answers as “unscorable”. Rater 5 as a representative of the German CF-patient organization and not a
care team member scored only the formal aspect of answers. The kappa values for agreement were interpreted according to the scale by Landis and Koch [13]:
agreement poor < 0; slight 0.00-0.20; fair 0.21-0.40; moderate 0.41-0.60; substantial 0.61-0.80; almost perfect 0.81-1.00). A p value of p < 0.05 was regarded to be
significant.
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Table 4 Tendency of the individual raters to score above or below the mean score
Content quality
% of answers 2 or
more points below
mean score
% of answers > 1 and
< 2 points below
mean score
% of answers > 1 and
< 2 points above
mean score
% of answers 2 or
more points above
mean score
Bias (score-
mean score)
(mean ± SD)
P (comparison
score with mean
score)
Rater
1
17.6 7.4 8.3 5.6 -0.45 ± 1.53 0.003
Rater
2
12 7.4 10.2 7.4 0.03 ± 1.43 0.839
Rater
3
15.9 8.4 6.5 5.6 -0.25 ± 1.50 0.084
Rater
4
4.6 2.8 10.2 21.3 0.68 ± 1.52 < 0.001
Formal quality
% of answers 2 or
more points below
mean score
% of answers > 1 and <
2 points below mean
score
% of answers > 1 and <
2 points above mean
score
% of answers 2 or
more points above
mean score
Bias (score-mean
score) (mean ±
SD)
P (comparison
score with mean
score)
Rater
1
24.1 17.6 0.9 0 -0.97 ± 1.13 < 0.001
Rater
2
2.8 3.7 2.8 0.9 0.00 ± 0.71 1.000
Rater
3
9.3 9.3 4.7 0.9 -0.25 ± 0.98 0.012
Rater
4
1.9 0 22.2 6.5 0.66 ± 0.89 < 0.001
Rater
5
2.8 2.8 19.4 6.5 0.56 ± 0.94 < 0.001
The numbers represent the percentage of expert answers that were scored more than one respectively two points above/below the mean score from all raters.
Rater 5 as a representative of the German CF-patient organization and not a care team member scored only the formal aspect of the expert answers. To assess
the bias of raters, the mean difference between the individual score given by a rater and the mean score of the group of raters was calculated. A p value of p <
0.05 was regarded to determine statistically significant differences between individual scores and the mean score.
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Figure 1 Content quality of answers from the Dutch language zone during the early and later period of the ECORN-CF system. Ten
expert answers from the early period (1-10) and ten expert answers from the later period (11-20) were assessed. Each column represents the
mean of the four scores given to a single answer (one additional rater scored only the formal quality). The squares represent the highest and
lowest scores given to that answer. The blue columns at the end of each group of ten expert answers represent the mean of the scores for all
answers of the early period and the later period, respectively; they did not differ between early and later period (p = 0.095). Dark grey columns
represent answers with a mean score of “good” quality.
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might be the lack of standards for a certain topic. At our
quality round table meetings, discrepant answers were
discussed with the experts/raters to identify reasons why
the raters came to such differing results. After a detailed
analysis of topics of those answers, it became evident that
most with divergent scores dealt with topics where no
standards or guidelines were available (eight out of eleven
answers). In these situations expert advice is likely to be
influenced by “access to best evidence”, local practice and
personal bias. This emphasizes the need to establish clear
consensus statements/guidelines to ensure local practice
is evidence based and consistent across centres. ECORN-
CF offers the opportunity to identify topics, for which
there is an urgent need to develop unanimous recom-
mendations. This identification process mainly takes part
during the control process of all answered questions in
the English archive as described in the Background sec-
tion. One concrete result of this process is the recently
published European paper on “Travelling with cystic
fibrosis” [14]. Other projects will follow leading to more
unequivocal counseling and treatment strategies for
patients with CF all over Europe.
Other factors which may have contributed to poor
agreement between individuals and over time include
the raters’ professional background (pediatricians, phy-
siotherapist, representative of CF-patient organization),
country of origin, exposure to lay questions and expert
answers over the time frame of the project. Training of
the expert panel undertaking quality assessment (e.g.
training seminars and teaching manuals) is key to
ensure a valid estimate of quality of expert advice.
Another goal which we pursued with the implementa-
tion of this quality assessment tool was to gather infor-
mation about the quality of answers in each language
zone and its development over time. We did not show
an improvement of quality of answers over the time
frame of the study and this is likely attributed to the
short time frame between the early and later periods as
well as the low numbers of questions in some language
zones. Furthermore, four out of six language zones
already had a “good” quality level of answers during the
early period, which remained “good” during the later
period.
The quality assessment of expert answers revealed
that, when taking all answers from all language zones,
the overall content and formal quality was on a good
level in both periods. However, in two out of six partici-
pating language zones (i.e. the Eastern European Mem-
ber States Romania and Lithuania), the level of quality
of answers remained on a “satisfactory” level. Unlike
some countries Romania and Lithuania had no experi-
ence with such a platform until the start of the
ECORN-CF project, the number of questions asked on
those platforms was quite low compared to other lan-
guage zones and the time between the early and later
period was relatively short, so that the possibility to gain
experience in order to improve the quality of answers
was lacking.
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at the end of each group of ten expert answers represent the mean of the scores for all answers of the early period and the later period,
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It seems to be of great importance to continue the
ECORN-CF project, in order to really achieve the antici-
pated aim: facilitating access to specific information for
patients with CF in all member state languages at the
same highest level of quality.
The best scores for content and formal aspects of
answers were achieved in the Dutch language zone
which also did not have prior experience with Internet
patient advice platforms. The Dutch language zone had
a unique approach to development of expert answers. A
local team of medical residents/registrars were encour-
aged to develop an answer which was then discussed in
a group forum. A standardized format was used for
group discussions which included: what aspects are
desirable to appear in the answer?; how is the given
answer judged from the other members of the group?; is
the content correct, what is lacking? All this information
was used to develop a complete answer which was
approved by the moderator before submission to the
ECORN-CF platform. Adoption of similar processes in
other language zones would improve quality and consis-
tency of answers in the ECORN-CF project.
Training on how best to provide expert advice is a
core part of a successful Internet patient advice plat-
form. Many ways appeared to be possible: training sup-
ported by short term visits e.g. according to the
“Pendleton Rules”. Using these rules the expert answer-
ing the question discusses what he did well, then the
trainer discusses what the expert did well, before he is
allowed to become critical. The expert describes what
could have been done differently and makes suggestions
for change. Another possibility could be the initiation of
workshops focusing on how to give answers of good
quality. Furthermore, it would be of great importance to
involve the patient organizations, e.g. for getting help in
recruiting the right experts for special topics or for com-
bining quality training with conferences.
Many Internet platforms where patients are able to
ask questions about specific illnesses are existing [8-11].
Current studies have focused on the reasons why
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patients turn to the Internet, how happy they are with
the answers and what kind of information they seek. To
our knowledge there are no studies on quality control
within these platforms.
With increasing access in both EU and non-EU coun-
tries, the Internet is now an important patient platform
for health care advice [6,7]. As a consequence, there is
increased need for quality control of such Internet infor-
mation platforms. The quality assessment tool in this
study is suitable for content quality control of expert
answers and a modified version could be used in other
expert advice Internet platforms. A mechanism to recog-
nize Internet platforms with rigorous inbuilt quality
control mechanisms (e.g. through a kite marking sys-
tem) would be useful so that patients could be confident
that they are receiving high quality advice.
Conclusions
This study describes the development and use of a qual-
ity assessment tool for expert answers to lay questions
within the ECORN-CF Internet platform. This tool is sui-
table for the assessment of content quality of answers, as
intra- and inter-rater variability could be leveled by using
the pooled score out of a group of four raters.
The quality of expert answers was high in most lan-
guage zones, with improvements possible in other lan-
guage zones. Implementation of strategies to improve
the quality of expert advice are important. The quality
assurance mechanisms inbuilt into ECORN-CF will
ensure that CF patients all over Europe have equal pos-
sibility of getting access to high quality expert advice on
their illness.
Additional material
Additional file 1: Training manual for quality assessment of expert
answers according to the newly developed scoring system. This
guide gives a detailed description with examples how to assess the
content and formal quality of an expert answer. The scoring system is
introduced which comprises points given to each aspect of content and
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formal quality and the calculation of the final content and formal score is
explained.
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